Peter Freitag

Rate of brain atrophy in relapsing MS decreases during treatment with IFNβ-1a

Martin Hardmeier, Stefan Wagenpfeil, Peter Freitag et al. · Neurology · 2005 · 105 citations

Neurorehabilitation, Neurodegenerative Diseases, Neuroimaging Biomarkers +14

Locoregional regulatory peptide receptor targeting with the diffusible somatostatin analogue 90Y-labeled DOTA0-D-Phe1-Tyr3-octreotide (DOTATOC): a pilot study in human gliomas.

Adrian Merlo, Oliver Hausmann, M. Wasner et al. · PubMed · 1999 · 96 citations

Engineering, Peptide Retention, Pathology +24

Local injection of the 90Y-labelled peptidic vector DOTATOC to control gliomas of WHO grades II and III: an extended pilot study

Tilmann Schumacher, Silvia Höfer, Kai Eichhorn et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2002 · 94 citations

Neuro-oncology, Medicine, Pathology +6

Motor, somatosensory and auditory cortex localization by fMRI and MEG

Christoph Stippich, Peter Freitag, Jan Kassubek et al. · Neuroreport · 1998 · 91 citations

Auditory Imagery, Neurolinguistics, Auditory Cortex +28

Image registration and subtraction to detect active T 2 lesions in MS: an interobserver study

I Leng Tan, Ronald A. van Schijndel, Franz Fazekas et al. · Journal of Neurology · 2002 · 48 citations

Engineering, Active T 2, Digital Pathology +17